Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...

A shared neuroimmune pathway involving CRH, mast cells, and Th17 cells may underlie the link between psoriatic arthritis and ...

Factors associated with multi-b/tsDMARD failure among patients with PsA included female sex, obesity, depression, axial disease, and increased disease activity.

Like psoriasis, psoriatic arthritis is becoming a highly crowded market, with new drugs like Novartis ... of its predecessor and all the new biologics may have to be content with a smaller ...

AbbVie today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA).1 This comes ...

Stelara was first approved for psoriasis 10 years ago, and follow-up indications in psoriatic arthritis and Crohn ... year despite approvals for new biologics drugs in its main therapeutic ...

Patients with psoriatic arthritis have delays in diagnosis compared with those with rheumatoid arthritis, according to study findings.

Joni Kazantzis was diagnosed with psoriasis at 15 and received a psoriatic arthritis diagnosis during the pandemic. She created a blog and social platform to offer the guidance she once needed ...

When India Bolton was diagnosed with psoriasis in college, she didn't expect a progression to psoriatic arthritis to happen so soon.

THE MANAGEMENT of plaque psoriasis has evolved significantly over the past two decades, with biologic treatments becoming ...